Craig A. Hokanson

476 total citations
8 papers, 347 citations indexed

About

Craig A. Hokanson is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Craig A. Hokanson has authored 8 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Craig A. Hokanson's work include CAR-T cell therapy research (3 papers), Virus-based gene therapy research (2 papers) and CRISPR and Genetic Engineering (2 papers). Craig A. Hokanson is often cited by papers focused on CAR-T cell therapy research (3 papers), Virus-based gene therapy research (2 papers) and CRISPR and Genetic Engineering (2 papers). Craig A. Hokanson collaborates with scholars based in United States, Italy and Switzerland. Craig A. Hokanson's co-authors include Michael J. Mendez, Roberto Crea, Craig A. Behnke, Stephen P. Mayfield, Peter Kirk, Rosa M. F. Cardoso, Beth A. Rasala, Philip A. Lee, Adrian E. Rice and Pamela J. Björkman and has published in prestigious journals such as Journal of Molecular Biology, Cancers and Human Gene Therapy.

In The Last Decade

Craig A. Hokanson

8 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig A. Hokanson United States	5	207	133	69	60	60	8	347
Jiawen Chen China	12	199 1.0×	87 0.7×	5 0.1×	14 0.2×	20 0.3×	22	358
Viktoria D. Paul Germany	7	284 1.4×	225 1.7×	67 1.0×	122 2.0×	2 0.0×	7	437
P. A. S. Mourão Brazil	8	82 0.4×	16 0.1×	20 0.3×	13 0.2×	57 0.9×	11	359
Patrick Gonschorek Switzerland	6	193 0.9×	11 0.1×	14 0.2×	5 0.1×	10 0.2×	7	295
Joseph L. Stodola United States	10	702 3.4×	118 0.9×	31 0.4×	49 0.8×	1 0.0×	12	810
Katharina Gegenschatz‐Schmid Switzerland	10	213 1.0×	22 0.2×	11 0.2×	4 0.1×	10 0.2×	16	322
Stefania Spada Switzerland	9	374 1.8×	2 0.0×	127 1.8×	100 1.7×	38 0.6×	12	525
Eddy Rubin United States	5	345 1.7×	2 0.0×	95 1.4×	9 0.1×	40 0.7×	6	458
A. Klein Germany	14	318 1.5×	31 0.2×	5 0.1×	16 0.3×	5 0.1×	19	392
Sebastian Schröder Germany	10	354 1.7×	7 0.1×	65 0.9×	31 0.5×	4 0.1×	17	462

Countries citing papers authored by Craig A. Hokanson

Since Specialization

Citations

This map shows the geographic impact of Craig A. Hokanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig A. Hokanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig A. Hokanson more than expected).

Fields of papers citing papers by Craig A. Hokanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig A. Hokanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig A. Hokanson. The network helps show where Craig A. Hokanson may publish in the future.

Co-authorship network of co-authors of Craig A. Hokanson

This figure shows the co-authorship network connecting the top 25 collaborators of Craig A. Hokanson. A scholar is included among the top collaborators of Craig A. Hokanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig A. Hokanson. Craig A. Hokanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Polerà, Nicoletta, Antonia Mancuso, Caterina Riillo, et al.. (2023). The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas. Cancers. 15(6). 1647–1647. 1 indexed citations

Riillo, Caterina, Nicoletta Polerà, Maria Teresa Di Martino, et al.. (2023). A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer. Journal of Translational Medicine. 21(1). 301–301. 2 indexed citations

Hokanson, Craig A., et al.. (2022). AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors. Biomedicines. 10(12). 3184–3184. 3 indexed citations

Hokanson, Craig A., et al.. (2011). Engineering highly thermostable xylanase variants using an enhanced combinatorial library method. Protein Engineering Design and Selection. 24(8). 597–605. 35 indexed citations

Rasala, Beth A., Philip A. Lee, Rosa M. F. Cardoso, et al.. (2010). Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnology Journal. 8(6). 719–733. 191 indexed citations

Rice, Adrian E., Michael J. Mendez, Craig A. Hokanson, Douglas C. Rees, & Pamela J. Björkman. (2009). Investigation of the Biophysical and Cell Biological Properties of Ferroportin, a Multipass Integral Membrane Protein Iron Exporter. Journal of Molecular Biology. 386(3). 717–732. 81 indexed citations

Hokanson, Craig A., et al.. (2003). Hybrid Yeast–Bacteria Cloning System Used to Capture and Modify Adenoviral and Nonviral Genomes. Human Gene Therapy. 14(4). 329–339. 8 indexed citations

Davis, Jennifer L., Rochelle M. Witt, Paul R. Gross, et al.. (1997). Retroviral Particles Produced from a Stable Human-Derived Packaging Cell Line Transduce Target Cells with Very High Efficiencies. Human Gene Therapy. 8(12). 1459–1467. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact